Disease:
Abnormalities, Drug-Induced
The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.
The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page.
| Gene ? |
Variant?
(147) |
Alternate Names ? | Chemicals ? |
Alleles
?
(+ chr strand) |
Function ? |
Amino Acid?
Translation |
|
|---|---|---|---|---|---|---|---|
| rs2306283 | NC_000012.11:g.21329738A>G, NC_000012.12:g.21176804A>G, NG_011745.1:g.50611A>G, NM_006446.4:c.388A>G, NP_006437.3:p.Asn130Asp, rs17389242, rs52832430, rs60767041 |
A > G
|
SNP |
N130D
|
|||
| rs4149056 | NC_000012.11:g.21331549T>C, NC_000012.12:g.21178615T>C, NG_011745.1:g.52422T>C, NM_006446.4:c.521T>C, NP_006437.3:p.Val174Ala, rs52816141, rs60037639 |
T > C
|
SNP |
V174A
|
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP 147
Overview
| Alternate Names: |
|
|---|---|
| PharmGKB Accession Id: | PA443224 |
| External Vocabularies |
|
Publications related to Abnormalities, Drug-Induced: 5
| Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study. Clinical pharmacology and therapeutics. 2010. Donnelly L A, et al.
|
|
|
|
Drug-induced liver injury: past, present and future. Pharmacogenomics. 2010. Daly Ann K.
|
|
|
Drug-induced autoimmunity. Current opinion in rheumatology. 2009. Dedeoglu Fatma.
|
|
|
Common variants at ten loci influence QT interval duration in the QTGEN Study. Nature genetics. 2009. Newton-Cheh Christopher, et al.
|
|
|
Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. American journal of medical genetics. Part A. 2004. Edison Robin J, et al.
|
